Skip to main content
. 2021 Oct;24(10):1358–1365. doi: 10.22038/IJBMS.2021.56771.12677

Figure 6.

Liraglutide inhibits activation of the NOD-like receptor protein 3 (NLRP3) inflammasome via sirtuin 1 (Sirt1) and AMP-activated protein kinase (AMPK) signaling in HG-treated H9c2 cells. (A) Representative images of Western blotting; (B) NLRP3 expression. Data are pre-sented as the mean±SEM, n=3 per group. **P<0.01 vs NG; ##P<0.01 vs HG; &&P<0.01 vs HG+LRG

Figure 6

NG: normal glucose; HG: high glucose; LRG: liraglutide